Past events
Credit Suisse 2021 London Global Healthcare Conference
March 2, 2021
Virtual Event
Fireside Chat: 12:00 p.m. GMT / 7:00 a.m. EST
Leerink 10th Annual Global Healthcare Conference
February 24, 2021
Virtual Event
Presentation: 8:00 a.m. EST
Downloads
Management attending JP Morgan 39th Annual Healthcare Conference
January 11 - 14, 2021
For meeting inquiries please contact investors@curevac.com.
Third Quarter and First 9 Months 2020 Financial Results and Business Updates – Conference Call & Webcast
November 30, 2020
CureVac N.V. (Nasdaq: CVAC) announced financial results and business updates for the third quarter and first nine months of 2020 on Monday, November 30, 2020. The company hosted a conference call and webcast on the same day at 4:00 p.m. CET / 10:00 a.m. EST.
Please find the corresponding press release, presentation slides, transcript and archived webcast below.
Positive Interim Phase 1 Data of CureVac’s COVID-19 Vaccine Candidate, CVnCoV – Conference Call & Webcast
November 10, 2020
The press release, presentation and transcript can be downloaded below, the archived webcast is available through the following link.
Downloads
Links
Conference Call “Strategic Partnerships to Deliver CureVac’s COVID-19 Ambition”
February 5, 2021
CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), hosted a conference call and webcast on Friday February 5, 2021 at 4:00 p.m. CET / 10:00 a.m. EST.
Please find the corresponding press release, presentation slides, transcript and archived webcast below.
Downloads
Links